Schizophrenia - Advances in drug therapy

Expert Opinion on Investigational Drugs

Volumn 6, Issue 7, 1997, Pages 857-866

  Reynolds, G P ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Antipsychotic drugs; Clozapine; Neurotransmitter receptors; Schizophrenia

Indexed keywords

2 [4 METHOXY 3 (2 PHENYLETHOXY)PHENYL] N,N DIPROPYLETHYLAMINE; 2 AMINO N [4 [4 (1,2 BENZISOTHIAZOL 3 YL) 1 PIPERAZINYL]BUTYL]BENZAMIDE; ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; ALPHA (4 FLUOROPHENYL) 4 (5 FLUORO 2 PYRIMIDINYL) 1 PIPERAZINEBUTANOL; BLONANSERIN; BRETAZENIL; CHLORPROMAZINE; CLOZAPINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; FANANSERIN; N CYCLOHEXYL 4 [4 (4 FLUOROPHENYL) 4 OXOBUTYL] 1 PIPERAZINECARBOXAMIDE; NEUROLEPTIC AGENT; NEUROTRANSMITTER RECEPTOR; OLANZAPINE; PEROSPIRONE; PRAMIPEXOLE; QUETIAPINE; REMOXIPRIDE; RISPERIDONE; SEROTONIN 2 RECEPTOR; SEROTONIN 2A RECEPTOR; SERTINDOLE; SULPIRIDE; THIORIDAZINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZD 3638; ZIPRASIDONE; ZOTEPINE;

AMENORRHEA; ANIMAL MODEL; DRUG EFFICACY; DRUG MECHANISM; DRUG RESEARCH; EXTRAPYRAMIDAL SYMPTOM; GALACTORRHEA; HUMAN; NONHUMAN; ORTHOSTATIC HYPOTENSION; RECEPTOR AFFINITY; REVIEW; SCHIZOPHRENIA; TARDIVE DYSKINESIA; VISUAL IMPAIRMENT; XEROSTOMIA;

EID: 0030822756     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.6.7.857     Document Type: Review

References (39)